InsidersTradesSigma
신라젠 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 신라젠 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 신라젠 has published 1 reports. Market capitalisation: €267.3bn. The latest transaction was reported on 5 March 2026 (Other). Among the most active insiders: 신라젠. All data is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 22,459 of 28,065 companies
30.6
score / 100
Value17
Quality45
FCF yld-9.8%
Earn yld-9.1%
EV/EBITDA·
ROE-21%
Gross mgn57%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 March 2026
About 신라젠
신라젠 is a biotechnology company focused on developing cancer treatments. It is listed on the XKRX market.